Preclinical data provided a boost to the company’s shares last week.
from https://www.bizjournals.com/baltimore/news/2017/08/14/why-analysts-think-novavaxs-flu-vaccine-could-be-a.html?ana=RSS%26s=article_search
via http://baltimorecheckbook.tumblr.com/post/164173333107
No comments:
Post a Comment